Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Clinical trial NCT03420313 · UNKNOWN

Trial details

NCT number: NCT03420313
Sponsor: University of Vermont
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-use Disorder

Start date: 2018-03-01
Primary completion: 2021-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.